Published in Am J Ophthalmol on January 01, 2005
Scientometric Analysis of the Journals of the Academy of Medical Sciences in Bosnia and Herzegovina. Acta Inform Med (2016) 1.21
Open access: the alternative to subscription-based medical publishing. West J Emerg Med (2008) 0.75
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Arch Ophthalmol (2003) 2.30
Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol (2004) 2.12
A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2010) 2.04
Viscocanalostomy in rhesus monkeys. Arch Ophthalmol (2004) 2.04
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Effectively implementing evidence-based medicine. Ophthalmology (2013) 1.95
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol (2013) 1.86
Safe and effective. Ophthalmology (2003) 1.73
New treatments for age-related macular degeneration. Ophthalmology (2005) 1.60
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Arch Ophthalmol (2002) 1.53
Vitamin usage patterns in the prevention of advanced age-related macular degeneration. Ophthalmology (2007) 1.51
Slitlamp, specular, and light microscopic findings of human donor corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2004) 1.46
The quest to eliminate "never events". Ophthalmology (2009) 1.42
Histopathology of radial keratotomy. Arch Ophthalmol (2005) 1.39
Not for your eyes: information concealed through publication bias. Am J Ophthalmol (2008) 1.39
Registration of clinical trials. Arch Ophthalmol (2005) 1.39
How to ensure our readers' trust: the proper attribution of authors and contributors. Am J Ophthalmol (2008) 1.38
Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol (2007) 1.35
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res (2004) 1.32
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology (2003) 1.30
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology (2002) 1.29
Prostaglandin-induced hair growth. Surv Ophthalmol (2002) 1.28
Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol (2007) 1.28
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res (2007) 1.21
Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology (2004) 1.19
Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology (2005) 1.13
Ocular tuberculosis. Arch Ophthalmol (2005) 1.12
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Invest Ophthalmol Vis Sci (2006) 1.08
Faster is better. Ophthalmology (2013) 1.07
Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci (2003) 1.03
Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina (2008) 1.02
Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Am J Ophthalmol (2013) 1.00
Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol (2002) 0.99
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci (2008) 0.99
Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol (2006) 0.98
Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology (2005) 0.97
Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina (2005) 0.96
Patients' preferences in choosing therapy for retinal vein occlusions. Retina (2007) 0.95
Nine-year incidence of visual impairment in the Barbados Eye Studies. Ophthalmology (2009) 0.93
Open-angle glaucoma and mortality: The Barbados Eye Studies. Arch Ophthalmol (2008) 0.93
Endophthalmitis is not a "never event". Ophthalmology (2012) 0.92
Use of best and final visual acuity outcomes in ophthalmological research. Arch Ophthalmol (2003) 0.92
Advanced keratomalacia with descemetocele in an infant with cystic fibrosis. Arch Ophthalmol (2005) 0.92
Retinal metastasis presenting as a retinal hemorrhage in a patient with adenocarcinoma of the cecum. Arch Ophthalmol (2005) 0.92
Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol (2003) 0.91
Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology (2003) 0.90
Four-year incidence of macular changes in the Barbados Eye Studies. Ophthalmology (2004) 0.89
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch Ophthalmol (2002) 0.89
Drug-induced cicatrising granulomatous conjunctivitis. Br J Ophthalmol (2007) 0.89
Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol (2002) 0.87
Management of macular edema from retinal vein occlusions: you can never have too many choices. Ophthalmology (2010) 0.86
Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center. Am J Ophthalmol (2006) 0.86
Aspergillus infection of the orbital apex masquerading as Tolosa-Hunt syndrome. Arch Ophthalmol (2007) 0.85
Neovascular age-related macular degeneration: roundtable. Retina (2005) 0.85
Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. Arch Ophthalmol (2005) 0.85
Acute idiopathic frosted branch angiitis. J AAPOS (2007) 0.84
Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. J Agric Food Chem (2011) 0.84
Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study. Acta Derm Venereol (2002) 0.84
The development and demise of a cataract surgery database. Jt Comm J Qual Improv (2002) 0.83
Pharmaceutical companies and ophthalmic research. Ophthalmology (2005) 0.83
Shaken adult syndrome: report of 2 cases. JAMA Ophthalmol (2013) 0.82
Neovascular Age-Related Macular Degeneration. Dev Ophthalmol (2015) 0.81
Eyelid fibrous hamartoma with conjunctival angioma in an infant. Arch Ophthalmol (2007) 0.81
Lessons learned: wrong intraocular lens. Ophthalmology (2012) 0.81
Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina (2004) 0.80
Vitelliform retinopathy in metastatic cutaneous melanoma with choroidal involvement. Arch Ophthalmol (2011) 0.80
Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg (2005) 0.80
Small choroidal melanoma. Ophthalmology (2008) 0.80
Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome. Arch Ophthalmol (2012) 0.80
Ophthalmic education: where have we come from, and where are we going? Am J Ophthalmol (2003) 0.79
The editorial process for medical journals: I. Introduction of a series and discussion of the responsibilities of editors, authors, and reviewers. Am J Ophthalmol (2003) 0.79
A clinicopathologic case study of two patients with pediatric orbital IgG4-related disease. Orbit (2013) 0.79
Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility. Arch Ophthalmol (2012) 0.78
Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas. Arch Ophthalmol (2005) 0.78
Transitional cell carcinoma of the lacrimal sac presenting with bloody tears. JAMA Ophthalmol (2013) 0.78
Stargardt disease in a patient with retinoblastoma. Arch Ophthalmol (2003) 0.78
Ocular trauma resulting in enucleation: A 12-year experience from a large regional institution. WMJ (2014) 0.78
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. PLoS One (2013) 0.78
Pocket of fluid in the lamellar interface after penetrating keratoplasty and laser in situ keratomileusis. Arch Ophthalmol (2003) 0.78
Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol (2008) 0.78
What is HIPAA and what effect may it have on our journal? Ophthalmology (2003) 0.78
1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol (2007) 0.78
Systemic non-Hodgkin B-cell lymphoma encountered as a vanishing choroidal mass. Arch Ophthalmol (2005) 0.78
Postoperative visual acuity in patients with fuchs dystrophy undergoing descemet membrane-stripping automated endothelial keratoplasty: correlation with the severity of histologic changes. Arch Ophthalmol (2012) 0.78
Enhanced reporting of potential conflicts of interest: rationale and new form. Am J Ophthalmol (2011) 0.77
Lichen simplex chronicus of the conjunctiva. JAMA Ophthalmol (2013) 0.77
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. Trans Am Ophthalmol Soc (2002) 0.77
Primary lymphoma of the central nervous system. Ophthalmol Clin North Am (2005) 0.77
A comparison of quantitative mapping and stereoscopic fundus photography grading of retinal thickness in diabetic eyes with macular edema. Ophthalmic Surg Lasers Imaging (2003) 0.76
Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol (2004) 0.76
A new approach to the management of diabetic macular edema. Ophthalmology (2010) 0.76
Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation. Ophthal Plast Reconstr Surg (2010) 0.75
Bilateral Primary Mucinous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg (2016) 0.75